Selected research
Industry Growth & Trends
Global Bifidobacterium Quadruplex Capsule Industry Growth and Trends Forecast to 2032
Market perspective
The global Bifidobacterium Quadruplex Capsule market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Bifidobacterium Quadruplex Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Bifidobacterium Quadruplex Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Bifidobacterium Quadruplex Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Bifidobacterium Quadruplex Capsule include Safeline Pharmaceuticals, Parchem fine & specialty chemicals., JEEVAN CHEMICALS & PHARMACEUTICALSJEEVAN CHEMICALS & PHARMACEUTICALS, Infloran, Goerlich Pharma, FAME Pharmaceuticals, Enomark, DM pharma and Bifido Co., Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Bifidobacterium Quadruplex Capsule market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Bifidobacterium Quadruplex Capsule market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Bifidobacterium Quadruplex Capsule market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Bifidobacterium Quadruplex Capsule.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Bifidobacterium Quadruplex Capsule market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Bifidobacterium Quadruplex Capsule Market by Company
Safeline Pharmaceuticals
Parchem fine & specialty chemicals.
JEEVAN CHEMICALS & PHARMACEUTICALSJEEVAN CHEMICALS & PHARMACEUTICALS
Infloran
Goerlich Pharma
FAME Pharmaceuticals
Enomark
DM pharma
Bifido Co., Ltd
Apollo Pharmacy
AGP Pharma
4U Pharma
4D Pharma PLC
Bifidobacterium Quadruplex Capsule Segment by Type
Adults
Children
Bifidobacterium Quadruplex Capsule Segment by Application
Hospitals
Clinics
Others
Bifidobacterium Quadruplex Capsule Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bifidobacterium Quadruplex Capsule market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bifidobacterium Quadruplex Capsule and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bifidobacterium Quadruplex Capsule.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bifidobacterium Quadruplex Capsule manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Bifidobacterium Quadruplex Capsule in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Adults
- Children
Applications
- Hospitals
- Clinics
- Others
Companies covered
- Safeline Pharmaceuticals
- Parchem fine & specialty chemicals.
- JEEVAN CHEMICALS & PHARMACEUTICALSJEEVAN CHEMICALS & PHARMACEUTICALS
- Infloran
- Goerlich Pharma
- FAME Pharmaceuticals
- Enomark
- DM pharma
- Bifido Co., Ltd
- Apollo Pharmacy
- AGP Pharma
- 4U Pharma
- 4D Pharma PLC
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Bifidobacterium Quadruplex Capsule Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Bifidobacterium Quadruplex Capsule Sales Estimates and Forecasts (2021-2032)
- 1.3 Bifidobacterium Quadruplex Capsule Market by Type
- 1.3.1 Adults
- 1.3.2 Children
- 1.4 Global Bifidobacterium Quadruplex Capsule Market Size by Type
- 1.4.1 Global Bifidobacterium Quadruplex Capsule Market Size Overview by Type (2021-2032)
- 1.4.2 Global Bifidobacterium Quadruplex Capsule Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Bifidobacterium Quadruplex Capsule Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Bifidobacterium Quadruplex Capsule Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Bifidobacterium Quadruplex Capsule Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Bifidobacterium Quadruplex Capsule Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Bifidobacterium Quadruplex Capsule Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Bifidobacterium Quadruplex Capsule Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Bifidobacterium Quadruplex Capsule Industry Trends
- 2.2 Bifidobacterium Quadruplex Capsule Industry Drivers
- 2.3 Bifidobacterium Quadruplex Capsule Industry Opportunities and Challenges
- 2.4 Bifidobacterium Quadruplex Capsule Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Bifidobacterium Quadruplex Capsule Revenue (2021-2026)
- 3.2 Global Top Players by Bifidobacterium Quadruplex Capsule Sales (2021-2026)
- 3.3 Global Top Players by Bifidobacterium Quadruplex Capsule Price (2021-2026)
- 3.4 Global Bifidobacterium Quadruplex Capsule Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Bifidobacterium Quadruplex Capsule Major Company Production Sites & Headquarters
- 3.6 Global Bifidobacterium Quadruplex Capsule Company, Product Type & Application
- 3.7 Global Bifidobacterium Quadruplex Capsule Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Bifidobacterium Quadruplex Capsule Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Bifidobacterium Quadruplex Capsule Players Market Share by Revenue in 2025
- 3.8.3 2025 Bifidobacterium Quadruplex Capsule Tier 1, Tier 2, and Tier 3
4 Bifidobacterium Quadruplex Capsule Regional Status and Outlook
- 4.1 Global Bifidobacterium Quadruplex Capsule Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Bifidobacterium Quadruplex Capsule Historic Market Size by Region
- 4.2.1 Global Bifidobacterium Quadruplex Capsule Sales in Volume by Region (2021-2026)
- 4.2.2 Global Bifidobacterium Quadruplex Capsule Sales in Value by Region (2021-2026)
- 4.2.3 Global Bifidobacterium Quadruplex Capsule Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Bifidobacterium Quadruplex Capsule Forecasted Market Size by Region
- 4.3.1 Global Bifidobacterium Quadruplex Capsule Sales in Volume by Region (2027-2032)
- 4.3.2 Global Bifidobacterium Quadruplex Capsule Sales in Value by Region (2027-2032)
- 4.3.3 Global Bifidobacterium Quadruplex Capsule Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Bifidobacterium Quadruplex Capsule by Application
- 5.1 Bifidobacterium Quadruplex Capsule Market by Application
- 5.1.1 Hospitals
- 5.1.2 Clinics
- 5.1.3 Others
- 5.2 Global Bifidobacterium Quadruplex Capsule Market Size by Application
- 5.2.1 Global Bifidobacterium Quadruplex Capsule Market Size Overview by Application (2021-2032)
- 5.2.2 Global Bifidobacterium Quadruplex Capsule Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Bifidobacterium Quadruplex Capsule Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Bifidobacterium Quadruplex Capsule Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Bifidobacterium Quadruplex Capsule Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Bifidobacterium Quadruplex Capsule Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Bifidobacterium Quadruplex Capsule Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Bifidobacterium Quadruplex Capsule Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Safeline Pharmaceuticals
- 6.1.1 Safeline Pharmaceuticals Company Information
- 6.1.2 Safeline Pharmaceuticals Business Overview
- 6.1.3 Safeline Pharmaceuticals Bifidobacterium Quadruplex Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Safeline Pharmaceuticals Bifidobacterium Quadruplex Capsule Product Portfolio
- 6.1.5 Safeline Pharmaceuticals Recent Developments
- 6.2 Parchem fine & specialty chemicals.
- 6.2.1 Parchem fine & specialty chemicals. Company Information
- 6.2.2 Parchem fine & specialty chemicals. Business Overview
- 6.2.3 Parchem fine & specialty chemicals. Bifidobacterium Quadruplex Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Parchem fine & specialty chemicals. Bifidobacterium Quadruplex Capsule Product Portfolio
- 6.2.5 Parchem fine & specialty chemicals. Recent Developments
- 6.3 JEEVAN CHEMICALS & PHARMACEUTICALSJEEVAN CHEMICALS & PHARMACEUTICALS
- 6.3.1 JEEVAN CHEMICALS & PHARMACEUTICALSJEEVAN CHEMICALS & PHARMACEUTICALS Company Information
- 6.3.2 JEEVAN CHEMICALS & PHARMACEUTICALSJEEVAN CHEMICALS & PHARMACEUTICALS Business Overview
- 6.3.3 JEEVAN CHEMICALS & PHARMACEUTICALSJEEVAN CHEMICALS & PHARMACEUTICALS Bifidobacterium Quadruplex Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 JEEVAN CHEMICALS & PHARMACEUTICALSJEEVAN CHEMICALS & PHARMACEUTICALS Bifidobacterium Quadruplex Capsule Product Portfolio
- 6.3.5 JEEVAN CHEMICALS & PHARMACEUTICALSJEEVAN CHEMICALS & PHARMACEUTICALS Recent Developments
- 6.4 Infloran
- 6.4.1 Infloran Company Information
- 6.4.2 Infloran Business Overview
- 6.4.3 Infloran Bifidobacterium Quadruplex Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Infloran Bifidobacterium Quadruplex Capsule Product Portfolio
- 6.4.5 Infloran Recent Developments
- 6.5 Goerlich Pharma
- 6.5.1 Goerlich Pharma Company Information
- 6.5.2 Goerlich Pharma Business Overview
- 6.5.3 Goerlich Pharma Bifidobacterium Quadruplex Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Goerlich Pharma Bifidobacterium Quadruplex Capsule Product Portfolio
- 6.5.5 Goerlich Pharma Recent Developments
- 6.6 FAME Pharmaceuticals
- 6.6.1 FAME Pharmaceuticals Company Information
- 6.6.2 FAME Pharmaceuticals Business Overview
- 6.6.3 FAME Pharmaceuticals Bifidobacterium Quadruplex Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 FAME Pharmaceuticals Bifidobacterium Quadruplex Capsule Product Portfolio
- 6.6.5 FAME Pharmaceuticals Recent Developments
- 6.7 Enomark
- 6.7.1 Enomark Company Information
- 6.7.2 Enomark Business Overview
- 6.7.3 Enomark Bifidobacterium Quadruplex Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Enomark Bifidobacterium Quadruplex Capsule Product Portfolio
- 6.7.5 Enomark Recent Developments
- 6.8 DM pharma
- 6.8.1 DM pharma Company Information
- 6.8.2 DM pharma Business Overview
- 6.8.3 DM pharma Bifidobacterium Quadruplex Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 DM pharma Bifidobacterium Quadruplex Capsule Product Portfolio
- 6.8.5 DM pharma Recent Developments
- 6.9 Bifido Co., Ltd
- 6.9.1 Bifido Co., Ltd Company Information
- 6.9.2 Bifido Co., Ltd Business Overview
- 6.9.3 Bifido Co., Ltd Bifidobacterium Quadruplex Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Bifido Co., Ltd Bifidobacterium Quadruplex Capsule Product Portfolio
- 6.9.5 Bifido Co., Ltd Recent Developments
- 6.10 Apollo Pharmacy
- 6.10.1 Apollo Pharmacy Company Information
- 6.10.2 Apollo Pharmacy Business Overview
- 6.10.3 Apollo Pharmacy Bifidobacterium Quadruplex Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Apollo Pharmacy Bifidobacterium Quadruplex Capsule Product Portfolio
- 6.10.5 Apollo Pharmacy Recent Developments
- 6.11 AGP Pharma
- 6.11.1 AGP Pharma Company Information
- 6.11.2 AGP Pharma Business Overview
- 6.11.3 AGP Pharma Bifidobacterium Quadruplex Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 AGP Pharma Bifidobacterium Quadruplex Capsule Product Portfolio
- 6.11.5 AGP Pharma Recent Developments
- 6.12 4U Pharma
- 6.12.1 4U Pharma Company Information
- 6.12.2 4U Pharma Business Overview
- 6.12.3 4U Pharma Bifidobacterium Quadruplex Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 4U Pharma Bifidobacterium Quadruplex Capsule Product Portfolio
- 6.12.5 4U Pharma Recent Developments
- 6.13 4D Pharma PLC
- 6.13.1 4D Pharma PLC Company Information
- 6.13.2 4D Pharma PLC Business Overview
- 6.13.3 4D Pharma PLC Bifidobacterium Quadruplex Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 4D Pharma PLC Bifidobacterium Quadruplex Capsule Product Portfolio
- 6.13.5 4D Pharma PLC Recent Developments
7 North America by Country
- 7.1 North America Bifidobacterium Quadruplex Capsule Sales by Country
- 7.1.1 North America Bifidobacterium Quadruplex Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Bifidobacterium Quadruplex Capsule Sales by Country (2021-2026)
- 7.1.3 North America Bifidobacterium Quadruplex Capsule Sales Forecast by Country (2027-2032)
- 7.2 North America Bifidobacterium Quadruplex Capsule Market Size by Country
- 7.2.1 North America Bifidobacterium Quadruplex Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Bifidobacterium Quadruplex Capsule Market Size by Country (2021-2026)
- 7.2.3 North America Bifidobacterium Quadruplex Capsule Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Bifidobacterium Quadruplex Capsule Sales by Country
- 8.1.1 Europe Bifidobacterium Quadruplex Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Bifidobacterium Quadruplex Capsule Sales by Country (2021-2026)
- 8.1.3 Europe Bifidobacterium Quadruplex Capsule Sales Forecast by Country (2027-2032)
- 8.2 Europe Bifidobacterium Quadruplex Capsule Market Size by Country
- 8.2.1 Europe Bifidobacterium Quadruplex Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Bifidobacterium Quadruplex Capsule Market Size by Country (2021-2026)
- 8.2.3 Europe Bifidobacterium Quadruplex Capsule Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Bifidobacterium Quadruplex Capsule Sales by Country
- 9.1.1 Asia-Pacific Bifidobacterium Quadruplex Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Bifidobacterium Quadruplex Capsule Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Bifidobacterium Quadruplex Capsule Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Bifidobacterium Quadruplex Capsule Market Size by Country
- 9.2.1 Asia-Pacific Bifidobacterium Quadruplex Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Bifidobacterium Quadruplex Capsule Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Bifidobacterium Quadruplex Capsule Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Bifidobacterium Quadruplex Capsule Sales by Country
- 10.1.1 South America Bifidobacterium Quadruplex Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Bifidobacterium Quadruplex Capsule Sales by Country (2021-2026)
- 10.1.3 South America Bifidobacterium Quadruplex Capsule Sales Forecast by Country (2027-2032)
- 10.2 South America Bifidobacterium Quadruplex Capsule Market Size by Country
- 10.2.1 South America Bifidobacterium Quadruplex Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Bifidobacterium Quadruplex Capsule Market Size by Country (2021-2026)
- 10.2.3 South America Bifidobacterium Quadruplex Capsule Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Bifidobacterium Quadruplex Capsule Sales by Country
- 11.1.1 Middle East and Africa Bifidobacterium Quadruplex Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Bifidobacterium Quadruplex Capsule Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Bifidobacterium Quadruplex Capsule Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Bifidobacterium Quadruplex Capsule Market Size by Country
- 11.2.1 Middle East and Africa Bifidobacterium Quadruplex Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Bifidobacterium Quadruplex Capsule Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Bifidobacterium Quadruplex Capsule Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Bifidobacterium Quadruplex Capsule Value Chain Analysis
- 12.1.1 Bifidobacterium Quadruplex Capsule Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Bifidobacterium Quadruplex Capsule Production Mode & Process
- 12.2 Bifidobacterium Quadruplex Capsule Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Bifidobacterium Quadruplex Capsule Distributors
- 12.2.3 Bifidobacterium Quadruplex Capsule Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst